| CDR1 |
P51861
|
cerebellar degeneration related protein 1
|
|
|
0.576 |
0.808 |
| HLA-H |
P01893
|
major histocompatibility complex, class I, H (pseudogene)
|
|
|
0.736 |
0.500 |
| HRES1 |
P13985
|
HTLV-1 related endogenous sequence
|
|
|
0.636 |
0.615 |
| IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| IFNR |
|
interferon production regulator
|
|
|
0.792 |
0.192 |
| IGHG3 |
P01860
|
immunoglobulin heavy constant gamma 3 (G3m marker)
|
|
|
0.513 |
0.769 |
| KIR2DS1 |
Q14954
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.537 |
0.769 |
| COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| THAS |
|
thoracoabdominal syndrome
|
|
|
0.560 |
0.808 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| H4C14 |
P62805
|
H4 clustered histone 14
|
|
|
0.541 |
0.692 |
| FCGR2C |
P31995
|
Fc fragment of IgG receptor IIc (gene/pseudogene)
|
Cell adhesion
|
|
0.610 |
0.654 |
| ERVW-1 |
Q9UQF0
|
endogenous retrovirus group W member 1, envelope
|
|
|
0.505 |
0.692 |
| RFH1 |
|
Renal failure, progressive, with hypertension
|
|
|
0.861 |
0.154 |
| IGAN1 |
|
IgA nephropathy
|
|
|
0.524 |
0.808 |
| ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
| H3C14 |
Q71DI3
|
H3 clustered histone 14
|
|
|
0.861 |
0.154 |
| NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
| H3C15 |
Q71DI3
|
H3 clustered histone 15
|
|
|
0.821 |
0.231 |
| LBX1-AS1 |
|
LBX1 antisense RNA 1
|
|
|
0.792 |
0.231 |
| SLEB4 |
|
systemic lupus erythematosus, susceptibility to, 4
|
|
|
0.861 |
0.154 |